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A THEORY ofthe mode of action of aromatic amines in producing carcinoma of
the bladder in man has been developed by Boyland and his colleagues (Boyland,
Wallace and Williams, 1955; Allen, Boyland, Dukes, Horning and Watson, 1957;
Wallace, 1959). They pointed out that in men working in the chemical industry
who have had contact with cx- or ,8-naphthylamine or benzidine the incidence of
cancer of the bladder is very high, but other organs are not affected. They
suggest that the absorbed amines are carried to the liver where they are meta-
bolised to ortho-aminophenols which are very rapidly conjugated with sulphate or
glucuronic acid by similar mechanisms to those they have demonstrated in rat
liver (Booth, Boyland and Manson, 1955) and that these conjugates are eventually
excreted by the kidney. In the urine the glucosiduronic acids (but not sulphates
which are resistant to hydrolysis) are exposed to the action ofhydrolytic enzymes
and thus free ortho-aminophenols are liberated. It is known that several ofthese
ortho-aminophenols, including 2-amino-1-hydroxynaphthalene can induce bladder
cancer in mice and dogs (Hueper and Wolfe, 1937; Hueper, Wiley and Wolfe,
1938; Bonser, Bradshaw, Clayson and Jull, 1956; Allen et al., 1957; and Wallace,
1959).
In people not exposed to the chemical hazard it is suggested that ortho-amino-
phenols derived from the metabolism of tryptophan may be one of the causative
factors in bladder cancer (Allen et al., 1957).
In a part of a series of investigations undertaken to examine this hypothesis
concerning the induction of bladder cancer, Boyland et al. (1955) demonstrated
that /3-glucuronidase activity is almost always increased in the urine of patients
with cancer of the bladder. They suggested that investigation of urinary ,-
glucuronidase activity might be of value in the prognosis of such patients.
Because of the concentration of suitable cases available to the Bristol Bladder
Tumour Registry, it was decided to investigate the significance of this urinary
enzyme, employing a wide range of controls.
MATERIAL AND METHODS
Material
The control series fell into three main groups:
Group 1.-This group consisted of 32 healthy subjects aged 17-61 years with
an average age of 33 years. Twenty-three (72 per cent) were male.
Group 2.-There were 87 patients in this group with a wide range of genito-
urinary (g.u.) diseases other than tumours. The average age was 44 years with
a range of 14-79 years.URINARY /3-GLUCURONIDASE ACTIVITY
Group 3.-Group 3 was a "miscellaneous" group of 120 patients with an
average age of 51 years and a range of 16-82 years, with various diseases not
connected with the genito-urinary tract. Patients with bone fractures were not
included but were assessed separately since they were found to have a significantly
raised enzyme activity.
As the patients in Groups 2 and 3 were selected at random from the hospital,
the average age was lower than in the patients with cancer of the bladder. Two
sub-groups consisting of patients over 50 years of age were therefore isolated from
these main groups.
In 2a, the sub-group of the other genito-urinary diseases, the average age was
59 years with 19 (91 per cent) male. In 3a, the sub-group of the "miscellaneous"
diseases, the average age was 60 years, of which 16 (47 per cent) were male.
Group 4. Group 4 consisted of bladder carcinoma patients who came into
hospital mainly for review cytoscopy. There were 86 patients with an average
age of 63 years ranging from 38-81 years and of these 82 per cent were male. In
none of these was there any evidence of association with the dye industry.
Method
Twenty-four hour specimens of urine were collected; the urine preservative
for about three-quarters of the investigation was 10 ml. benzene, but in the later
stages, in accordance with the revised method of Boyland et al. (1957), this was
changed to 10 ml. of a 20 per cent solution of thymol in benzene. The thymol
with benzene had no effect on the enzyme level but had a greater bacteriocidal
effect than benzene alone. It was found that the enzyme in urine of normal pH
was stable for at least seven days with the preservative at room temperature; this
was in agreement with the results of Boyland et al. (1955). In the bladder cancer
group the urine was collected before cystoscopy. In some patients it was un-
avoidable that pre-operative drugs were given during the last hour or so of the
24-hour urine collection. In all groups it was noted whether the patient had beein
receiving drugs or had been pyrexial during the collection and whether there had
been any operative procedure within the previous fortnight. The pH and specific
gravity of the urine were determined. In some cases the creatinine value was
estimated as a further check on whether the collection had been complete. Ofthe
101 specimens on which such determinations were made only eight had a creati-
nine value of less than 0-5 g./24 hours. This was taken as an indication of the
level of accuracy in the urine collection. Unfortunately these estimations were
not carried out at the beginning of the whole investigation where collection errors
might be expected to have been greater.
Approximately 15 ml. of urine was centrifuged in a conical tube at 2000 r.p.m.
for at least 10 minutes. In a proportion of cases one drop of the deposit was exa-
mined under the microscope and patients with deposits containing more than 20
red blood corpuscles in the drop were considered to have excess red cells. Red
cells have negligible ,8-glucuronidase activity (Fishman, Springer and Bruinetti,
1948), but their presence in urine indicates the possibility of contamination with
serum which has an activity of up to three times that of urine in normal subjects.
The f8-glucuronidase activity of the supernatant fluid, and in some cases the
urinary deposit also, was determined by a slight modification of the method of
Boyland, Gasson and Williams (19.57) which was derived from the original method
of Talalay, Fishman and Huggins (1946). Duplicate samples of either 1 ml. of
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supernatant urine or an appropriate volume ofthe deposit resuspended in distilled
water were incubated with 1 ml. acetate buffer (0 2 M, pH 4.5) and 1 ml. phenolph-
thalein mono-,8-glucuronic acid (0.05 per cent in 10 per cent ethanol) in stoppered
tubes at 370 C. for 15 hours. At the end of this time 1 ml. of urine was added to
the blank and a sufficient volume of 0 1 N NaOH was added to each tube just to
reach the pink coloration of the free phenolphthalein end-point. Then 1 ml. of
glycine buffer (0.4 M, pH 10.5) was added. The solutions were centrifuged for 5
minutes at 2000 r.p.m. and the absorption at 550 m/t read in a Hilger spectro-
photometer. With urines of different buffering power it was necessary to add
different volumes of 0-1 N NaOH to reach the end-point and allowance was made
for the different final volumes obtained. The activity was expressed in the same
unit used by Boyland et al. (1957), namely, 1 unit is the amount ofenzyme liberat-
ing 1 ,ug. of phenolphthalein per hour at 370 C.
In 50 individuals the urine was investigated to determine the presence of heat
stable f8-glucuronidase inhibitors or activators. The enzyme activity of various
concentrations of urine diluted with distilled water was compared with the same
concentrations of urine diluted with boiled urine. The results were plotted
graphically, the percentage activity against the amount of dilution. In those
cases where the urine diluted with water gave a curve on the graph, while the same
urine diluted with boiled urine gave a straight line, it was assumed that an inhi-
bitor was present. Since these investigations were made on the unpurified enzyme
the term inhibitor was used in its broadest sense. This inhibitor decreased in
concentration as the urine was diluted with distilled water but remained constant
when diluted with boiled urine (Boyland et al., 1955). The inhibitor index (150)
was calculated as the ratio:
Unit of activity of 1 ml of a solution of urine diluted with
an equal volume of distilled water
Unit of activity of 1 ml. of a solution of urine diluted with
an equal volume of boiled urine
With regard to the reproducibility of the method, the enzyme activity in 12
equal aliquots of urine was estimated; the mean value of the liberated phenol-
phthalein was 4-9 ,ug./ml. with a standard deviation of 0-1 representing an error
of almost 3 per cent.
The accuracy of the method was more difficult to determine. The chief errors
arose from the different ionic and non-ionic constituents and buffering powers of
the different urines. As Boyland et al. (1957) have shown, 0-2 M acetate buffer
was sufficient to bring any urine within the normal range to a pH of 4X5-4*8. In
the investigation of urines with pH over 7 0 it was necessary to adjust the urine
to pH 4-5 with acetic acid before adding the pH 4-5 buffer. At the end of the
experiment, after the addition of 0-1 N NaOH and 0 4 M glycine, it was found
that the pH ranged from 10-1-10*5. Since the standard phenolphthalein curve
was determined at pH 10-5 there was, in some determinations, an error due to a
difference of the phenolphthalein colour intensity at a pH different from that of
the standard. The magnitude of this error was determined in a series of 61 urines.
The usual duplicate solutions were set up for incubation with an extra tube con-
taining 1 ml. urine, 1 ml. 0 2 M acetate buffer and 0 5 ml. 10 per cent ethanol.
At the end of the incubation time the same volumes of 0-1 N NaOH and 0 4 M
glycine were added to the extra tube as were to the duplicate tubes and 0 5 ml,
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of a standard solution of phenolphthalein was then added to this third tube.
The colour developed in this tube was compared with the colour developed by
the standard phenolphthalein in glycine buffer at pH 1]0 5. The percentage
difference was calculated. The mean percentage difference for the 61 urines was
6-9 with an S.D. of ±4-5. This difference included the error due to the different
final pH and the small salt and protein indicator error of phenolphthalein.
RESULTS
Before dealing with the range of,8-glucuronidase activity in the cases of cancer
of the bladder and the different groups of controls, the results of investigating
various factors which might be expected to influence this enzyme activity are
presented. A wide range of drugs was given to the patients as part of their treat-
ment. Excluding the steroid hormones, particularly cortisone, which appeared
to raise the enzyme activity, the general picture was that most drugs and anti-
biotics did not have Mny appreciable effect. As Boyland and W17illiams (1956) had
noted, patients with pyrexia often had a raised enzyme value.
TABLE J.-/3-glucuronidase Activity of the Urinary Sediment
(a) In normal subjects
fi-glucuroiiidase activity
I-
Sediment
Units/ml.
original,
Iniitials Age Sex urine
G.R 35 M. . 0
P. K 34 ,, 003
K. C 24 0 04
L. B . 60 . 0 04
M. T 19 . , 0 07
J. K . 25 F. 0 07
J.R 29 , 0 07
M1. B 20 . . . 009
C. P- 30 F. . 0.10
D.F 25 M. 0.10
M. T- 29 F. . 011
F. K 44 M. 0-12
D.L 18 . F. 0-12
M.B 28 M. 0-13
A. K 20 . F. 014
V.B 20 ,, 0-17
P.V 28 ,, . 0-18
J.A 21 0-31
Supernatant
Units/ml.
Units/day urine Units/day
0 0 36 765
32 0 76 830
5)6 1 37 1800
83 0( 83 1910
76 1- 02 1140
85 1- 3 1610(
95 1 - 07 1400
102 0 83 963
150 0 73 1300
166 0 69 1120
176 1-0 1650
60 10 02 1150
7} 1 -115 697
203 1 05 1570
199 0-51 724
142 0 .'94 795
435 087 2100
252 0-96 784
(a) /3-glucuronidase activity in urinary sediment
Table I (a) demonstrates that the /-glucuronidase activity of the small urinary
deposits found in 18 normal subjects ranged from 0-450 units per day and the de-
posit in women usually had a higher activity than in men. The enzyme level was
increased in some cases of bladder cancer (Table I (b)) and also in other diseases.
During the investigation of 64 specimens there appeared to be no consistent
relation between the activity in the deposit and the activity of the supernatant
urine.
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TABLE I.-,/-glucuronidase Activity of the Urinary Sediment
(b) In patients with cancer ofthe bladder
,6-glucuronidase activity
Sediment
r ^- 5 Supernatant
Units/ml. A
original Units/ml.
Age Sex urine Units/day urine Units/day
76
78
72
65
59
68
72
70
62
M.
F.
M.
,,~
0
0
0-01
0- 014
0 05
0*05
0-1
0-23
0 37
0
0
34
27
30
132
194
426
985
With red corpuscles contamination
164 . 66 F. 1-05 1439
16 . 55 . M. 1-36 2860
0-48
0-66
1*7
1.5
1-74
0-88
0 49
0-85
1*1
1-77
1 02
1140
920
3900
2860
1060
2340
930
1560
3100
2420
2140
+ = A tumour recurrence was found during the cystoscopy immediately following the urine
collection.
- = No recurrence.
(b) The presence of f8-glucuronidase inhibitors in the supernatant urine (Table II,
Fig. 1)
Of 52 men investigated from all groups, 45 (86 per cent) had an J50 of more
than 1 1 which was taken to indicate the presence of inhibitors. In 21 women,
r_
Q
u
v
Unboiled urine concentration per cent
FiG. 1.-Inhibition of urinary ,9-glucuronidase by substances present in urine.
O Diluted with distilled water.
x Diluted with boiled urine.
11 (52 per cent) had an J50 value of more than 1-1. If these results were due to
the presence of a single substance, this inhibitor was present in men as frequently
in cancer of the bladder (in 12 out of 13 cases) as in other disease (28 out of 34)
or in normal subjects (in each of the 5 subjects investigated). In the urine from
110
Patient
No.
165
405
45
404
377
196
166
243
154
±
+
+
±
+
+
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women the corresponding results were: canicer ofthe bladder (one out oftwo cases),
other disease (7 out of 12) and normal subjects (3 out of 7).
Group
1. Normal subjec
2. Other gen
urinary disec
TABLE II. The Inhibitor Index of Supernatant Urine
Patient's
No. or Patient
initials Sex J50 Group No.
ts . C. P F. . 0-42 3. Miscellaneous " 15
A. K ,, 1-00 diseases 238
M.C 100 193
J. G ,, -10 423
J. H 1-30 223
J.C ,, . 1-40 242
M.B M. . 147 224
D.F ,, . 1-50 228
G.R . 1-56 195
J.B , . 1-70 219
P.V F. . -80 13
F. K A. 1 90 Hi
i t o -
ases
241 F. 003
371 . M. 1-00
299 F. 1- 00
139 . M. . 1-00
249 F. . 1- 06
251 M. 1-10
259 . 1-17
250 . 1-17
255 . ,, . 1-18
220 . 1- 20
237 . ,, 1- 22
138 1-30
256 . . 1- 30
1-30
257 . ,, . 1- 36
231 . ,, 1-41
121 1- 43
422 ,, . 1- 44
High urinary pH
227 . F. . 1- 20
198 M. . 1- 20
140 ,, 1- 30
112 ,, . 1-44
52 ,, . 1- 54
Within 14 days
after operation
205 . F. 0.80
240 1- 08
254 . M. 1- 18
135 1-60
248 2- 25
4. Cancer of the
bladder
136
a
245
247
204
199
202
203
196
165
154
45
405
166
152
404
279
377
16
378
C
164
16
s
Sex 150
F. 0 76
.M31. 1.10
1-10
1-17
1-36
1-45
1-60
1-60
2-00
2-43
F. 2-63
igh urinary pH
M. . 2-20
Vithin 14 days
,fter operation
M. 1-05
1-17
1-66
1-73
2-00
2-0
F. 0 79
M. 1.00
1-17
1-18
1-27
1-43
1-48
1-50
1-55
1-57
1-70
1-78
With red cell
ontamination
F. 1-80
M. . 2-59
The urine from 3 women contained an " activator " of some kind, since on
dilution with distilled water the decrease in enzyme activity was greater than on
dilution with boiled urine (Fig. 2). In each of 4 normal subjects and 2 patients
on whom these investigations have been repeated, the inhibition or activation
originally demonstrated remained unchanged.
(c) Urinary /J-glucuronidase activity during the menstrual cycle
An attempt was made to correlate the enzyme activity with the phases in the
normal menstrual cycle. Four normal women between the ages of 20-30 years
IIIF. J. W. LEWIS AND CONSTANCE H. J. PLAICE
U
a
0
Unboiled urine concentration per cent
FIG. 2.-Activation of urinary ,f-glueuronidase by substances present in some
women's urine.
O Diluted with distilled water.
X Diluted with boiled urine.
Days
FIG. 3.-Urinary enzyme activity throughout the menstrual cycle in four young women.
For each individual the lower graph represents the activity per ml. urine and the upper
graph represents the total daily enzyme output.
Menstruation.
c Contaminated by menstrual blood.
Time of ovulation.
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collected 24-hour specimens throughout one cycle and noted the time of ovulation
by recording waking temperatures. Since the cycles were normal it was assumed
that peak oestrogen output occurred at about ovulation time and just before
iiienstruation (Pedersen-Bjergaard and T0nnesen, 1948). The urinary f-glu-
curonidase activity appeared to be unrelated to the phases of the menstrual cycle
except that in specimens grossly contaminated with menstrual blood and tissue
the activity was elevated (Fig. 3).
TABLE III.--The /3-glucuronidase Activity in Infected Urine where the pH
is Within Normal Limits
fl-glucuronidase
activity
(units/ml.)
1-10
1-77
0-21
* 0.66
0-84
1 50
0-96
0.99
1-29
1 51
1 51
1-51
1-70
0 3
0-63
0 93
1 05
1 08
1-10
0-51
0-66
0 90
1 41
0 90
1 60
0-81
Organism
Tubercle bacillus.
Mixed coliforms.
Coliforms and B. proteus.
Coliforms.
Coliforms and staphylococci.
B. proteus.
E. coli.
Mixed coliforms.
E. coli.
Ps. pyocyanea.
Ps. pyocyanea.
E. coli.
E. coli.
E. coli.
E. coli.
Mixed with E. coli.
Aerobacter aerogenes.
Ps. pyocyanea.
Aerobacter aerogenes.
Mixed coliforms.
Mixed coliforms and Staphylococcus aureus.
E. coli.
Mixed.
E. coli.
Aerobacter aerogentes.
E. coli.
Coliforms.
Coliforms and Enterococci.
(d) The effect of alkaline conditions of the urine upon the fi-glucuronidase activity
(Tables III and IV)
With slight urinary infection where the pH was not raised above pH 7 0 the
enizyme activity was not significantly altered (Table III). In 5 patients with cancer
of the bladder the urine was grossly infected and in 4 cases the pH was raised to
a value of 930 or more. In these patients the urinary enzyme activity was in-
creased. In patients suffering from other diseases where the pH of the urine was
abnormally high, in several cases (6 out of 20), the enzyme activity was elevated
(Table IV). The effect of incubating normal urine with B. proteus or E. coli before
the assay was variable, the enzyme activity being sometimes increased and some-
times decreased. When the pH of normal urine was increased by the addition of
alkali the enzyme activity fell.
10
Patient
No.
299
174
148
150
122
109)
112
244
130
110
161
230
79
194
240
83
256
120
242
218
274
58
253
226
301
246
250
pH
5-2
5.2
5.3
5-6
5-6
5.6 .5;- 7 5.7
6-0
6-0
6-0
6-0
6-0
6 0
6-2
6-2
6-2
6;2
6-2
6-2
6-4
64
6-4
6-4
6-58
6-6
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TABLE IV.-Urinary /8-glucuronidase Activity in Patients with Urine ofHigh pH
Patient
No.
296
287
213
278
305
222
169
86
81
63
160
pH
7-14
9 0
9 0
9-2
>90
7-2
7-28
7.4
7.5
7-6
8-0
295 . >8-0
108
50
227
140
105
198
64
248
26
89
149
54
112
>8-0
>8-0
>8-0
8-5
9-0
9-0
>9-0
>9-0
>9-0
>9 0
>9-0
>9 0
>9-0
B-glucuronidase
activity
Units/mi.
urine Units/day
4 95 3,960
2-17 4,180
2 40 3,820
2- 77 11,400
3- 28 3,180
0-93
0-69
1-14
2-30
1-70
2-19
0
0-81
1- 18
2-04
0-72
1-68
7-65
0-72
1-14
1-57
2-93
3-96
4-20
9-45
1,311
2,640
2,040
1,840
3,57
4,42
2,09
2,84
4,89
45
2,14
33,6C
63
1,53
2,15
1,57
10,30
11,05
5,76
Organism
Enterococci.
B. proteus.
B. proteus.
Sterile.
Sterile.
70 Aerobacter aerogenes.
20 . Non-haemolytic strepto-
cocCi.
0 Coliforms + Streptococcus
faecalis.
)0 Mixed coliforms.
[0 . Coliform.
36 . -
53 . E. coli.
[0 . B. proteus.
)0 . Streptococcus faecalis and
B. proteus.
30 . Diphtheroid.
0 . Aerobacter aerogenes.
i5 B. proteus.
70 . B. proteus.
)0
. - i0
;O
(e) Urinary /3-glucuronidase activity after operation (Table V)
It was found. that within 8 days after major operations performed on parts of
the alimentary canal the enzyme activity was significantly increased, which is
in agreement with the observation of Boyland and Williams (1956). On the other
hand minor operations upon skin or fairly superficial muscle did not result in an
elevation of the enzyme activity. The effect of operations on the genito-urinary
tract upon the enzyme activity was variable.
TABLE V.--Urinary 3-glucuronidase Activity within 8 Days of Operation
Urinary ,-glucuronidase activity
Units/ml.
urine
"I
Mean S.D. S.E.
1-19 0-39 0-088
Major . 13 3-72 1-68 0-466
" t " test against
normal subjects
t P
0-98 Between
0-4 and
0-3
8-08 Less than
0-01*
Units/day
Mean S.D. S.E.
1523 569 127
3534 1750 486
" t " test against
normal subjects
1- -k
t P
0-52 0-6
5-37 Less than
0.01*
S.E. = Standard error of the mean.
* Significantly different.
Disease
Cancer of the
bladder
Any other
disease
Type of
surgery n
Minor . 20
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,8-glucuronidase activity in normal subjects, in cancer of the bladder and in other
diseases (Table VI)
Group 1.-In normal subjects the mean activity/ml. urine was 1-05 units with
a standard error of the mean of 0-098 and the mean daily excretion was 1405
units/day with a standard error of 160. Boyland et al. (1957) found the normal
range to be 0-05-1-2 units/ml. and when the daily outputs were calculated from
their published figures the mean was 1304 units/day with a range of 162-4890
units.
TABLE VI.-Urinary /3-glucuronidase Activity in Normal Subjects and in Patients with
Different Diseases
Average
age
Group (years)
1. Normal subjects . 33
2. G.U. diseases (totalage 44
range)
2a. G.U. diseases (over 50 59
years of age)
3. " Miscellaneous " dis- 51
eases (total age range)
3a. " Miscellaneous " dis-
eases (over 50 years
of age)
3b. Fractures .
4. Cancer ofthe bladder . 63 71
Units/ml.
A-
n Mean S.E. S.D.
32 1-05 0 098 0 55
41 1-21 0-122 0 78
21 1-31 0-227 1-04
55 1-16 0 084 0 62
34 1-35 0-121 0*70
27 2-55 0-213 1-24
" t " test against
normal subjects
t P
0 98 Between
0-4 and
0 3
1- 14 Between
0 3 and
0-2
0 82 Between
0-5 and
0 4
1 91 Between
0 1 and
0 05
6-14 0.01*
1-18 0 068 0 58 1-073 Between
0-3 and
0-2
S.E. = Standard error of the mean.
* Significantly different.
Units/day
Mean S.E. S.D.
1405 160 893
2353 270 1707
" t " test against
normal subjects
t
2-8
2251 441 2023 2-06
1719 141 1047 1-4
1649 163 950 1-02
2990 321 1697 4-55
1831 100 831 2*3
p
0.01*
Between
0 05 and
0-02*.
Between
0-2 and
0-1.
Between
0 3 and
0-2.
Less then
0.001*.
0 025*
TABLE VII.-Daily Volume of Urine Excreted by Normal Subjects and
Patients with Different Diseases
Group
1. Normal subjects
2. Genito-urinary diseases (total agerange)
2a. Genito-urinary diseases (over 50 years
of age)
3. "Miscellaneous" diseases (total age
range)
3a. "Miscellaneous" diseases (over 50
years of age)
3b. Fractures
4. Cancer of the bladder
Volume of
urine excreted
(ml.)
Mean S.E. S.D.
1419 110 577
2094 137 901
1824 165 755
1462 87 635
1360 34 625
1173 108 571
1739 68 601
* Significantly different.
" t " test against
normal subjects
P
3-52 Less than 0 001*.
2- 108 Between 0 05 and
0-02*.
0 356 Between 0 8 and
0 7.
0 379 Between 0*8 and
0 7.
1 529 Between 0 2 and
0*1.
2-408 Between 0 02 and
0.01*.
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TABLE VIII
(a) Comparison ofthe 24-hour enzyme activity in subjects from the normal
and " miscellaneous " groupswho hadexcretedover 1700ml. urine, with the
activity in patients with carcinoma of the bladder and with other genito-
urinary diseases.
" t " tests
A- A
Mean
volume
urine
excreted
Group n (ml.)
1+3>1700 . 19 . 2150
Urine volumes
C-
Mean Against
daily carcinoma Against other
enzyme bladder group g.u. diseases
activity A
(units) t P t P
2355 . 2*78 <0.01* 0*253 0 80
24-hour enzyme activity
Against
carcinoma
bladder group
t P
2-37 0-02*
Against other
g.u. diseases
t P
0 005 >0 9
(b) Comparison ofthe 24-hour enzyme activity in patients with carcinoma ofthe
bladder and other genito-urinary diseases who had excreted less than 1900 ml.
urine, with the activity in normal subjects.
Mean volume
urine excreted
(ml.)
1323
Mean enzyme
activity
(units)
1687
* Significantly different.
" t " test against normal subjects
C-
A
24-hour
Urine volumes enzyme activity
t P t P
0* 899 Between 0* 1*453 Between 0*2
and 0 3 and 0 I
Groups 2, 3 and 4.-The results in this section are from urine within the normal
pH range and not contaminated by excess red cells. During the urine collection
the patients were not suffering from pyrexia, had not undergone operations within
the previous fortnight and were not having steroid hormone therapy.
In the original " miscellaneous " group it became obvious that patients with
fractures had an enzyme activity higher than any other. These cases were there-
fore removed and considered separately.
Apart from this (Group 3b) the /?-glucuronidase activity per ml. urine in any
ofthe groups (2, 2a, 3, 3a, or 4) was not significantly different from that in normal
subjects.
The daily enzyme output in both the total " miscellaneous " group (3) and its
sub-group ofpatients over 50 years of age was also not significantly different from
the normal value. The enzyme output per day, however, in the total " other
genito-urinary diseases "(Group 2) and in its sub-group was significantly increased
as it was also in the group of cancer of the bladder cases (4).
It was suspected that the increased enzyme output per day in both groups 2
and 4 might be a mere statistical effect ofthe significantly larger volumes of urine
excreted (Table VII) as a result ofthe greater fluid intake encouraged in these two
groups of patients. Since it was very difficult to obtain reliable information about
the fluid intake the following, admittedly arbitrary, method was used to test such
a hypothesis. The daily enzyme output values of individuals in the normal and
"' miscellaneous " groups who had excreted a volume of urine of 1700 ml. or more
Group (1 + 3 > 1700), were statistically compared with the enzyme activity in
Groups 2 and 4 (Table VIII). No significant difference was found between the
Group
2+4< 1900
n
55
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mean urine volumes in this (1 + 3 > 1700) group and the other genito-uriniary
diseases (2), nor was there any significant difference in the daily enzyme exeretionl.
It was even found that the mean urine volume of group (1 + 3 > 1700) was
significaintly higher than the mean volume of the carcinoma of the bladder group
(4), and, correspondingly, the daily enzyme activity in groups (1 + 3 > 1700)
was higher than in the cancer of the bladder cases.
As an added check, all results from patients with carcinoma of the bladder anid
other genito-urinary diseases who had excreted a daily volume of less than 1900
ml. (again an arbitrary figure), were combined (group (2 + 4 < 1900)) and comn-
pared with the enzyme activities in normal subjects (1). There was no signiificalnt
difference in the enzyme output in these two groups; the meani volumes of urinie
excreted were also not significantly different.
The results from Groups 1, 2a, 3a and 4 indicated that, although the mean
values were higher in the older groups, age had no significant effect on the urinary
/3-glucuronidase activity/ml. urine. In both the sub-groups of patients over 50
years of age the mean volumes of urine excreted were less, but not significantly,
than in the corresponding main group, and the mean daily enzyme activities were
also lower.
In the fracture group, 3b, both the activity per ml. of urine and the daily
enzyme output were significantly raised compared with the normal values for at
least 10 days after the fracture (Lewis and Plaice, 1959). As the mean volumne of
urine excreted was lower than normal it was assumed that this was in fact a true
difference.
DISCUSSION
The enzyme concentration per ml. of urine is an indication, at any particular
time, of the possible hydrolytic opportunities, but the length of time the bladder
mucosa is exposed to the carcinogens is another factor which must play a part.
The enzyme activity per nl. of urine was not significantly increased in the
cancer of the bladder patients, which is not in accord with the results of Boyland
et al. (1955). When, however, the enzyme activity per day was considered, both
these and the other urinary tract diseases had significantly inicreased activity
compared with the normal value. This increase was not only inot specific for the
cancer of the bladder patients but it appeared to be a statistical consequenice of
the greater volumes excreted. This apparent relationship between the volume
excreted and the daily enzyme output is difficult to understand.
Boyland and his colleagues (1955) found no 3-glucuronidase inhibitors in the
urine whereas in the present series 8t6 per cenit of the samples from men anid 52
per cent from women had an inhibitor present. The presence of an endogenous
/3-glucuronidase inhibitor in maniy types of tissue and in serum is well kniown
(XValker and Levvy, 1953) and an enzyme inhibitor in uriine has been demonstrated
(Abul-Fadl, 1957). Levvy (I956) points out that an importaint cause ofinhibitionl
of hydrolysis of a particular glucuronide is the presence in urine of other glu-
curonide conjugates. This will in any case introduce errors ofunknown magnitude
in the determination of urinary fl-glucuronidase activity. It is of interest to note
that under the experimental conditions used in this study, the urine of some
women contained no inhibitors and appeared to have " activators ". If /3-glu-
curonidase plays an important role in releasing bladder carcinogens it is therefore
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difficult to understand why women have a lower incidence of bladder cancer than
men unless there is some difference between the sexes in the length of time that
the carcinogen can act upon the bladder epithelium.
The method used in this work and in the investigation of Boyland et al. (1955)
entails a dilution of urine with acetate buffer and substrate. This dilution of any
inhibitor or " activator " does not give an accurate picture of the enzyme activity
in the bladder. Walker and Levvy (1953) discussing an endogenous inhibitor
affecting rat-liver f8-glucuronidase activity in in vitro investigations state that it
is by no means certain that the inhibitor has any effect in vivo. To study the
enzyme in the liver they homogenised the tissue, thus disrupting the cell con-
stituents and perhaps causing contact of enzyme and inhibitor which would
not naturally occur. In urine however, it is more likely that the inhibitor is as
active in the bladder as it is in vitro. The enzyme activity in the bladder is usually
less than that estimated in vitro at an optimum pH of 4-5. It is possible that the
inhibitor or activator action differs at the pH of the urine in the bladder from
that under the experimental conditions (Smith and Mills, 1953). Odell and Fishman
(1950), investigating the /8-glucuronidase activity in human endometrium, found
that there was a variation of activity during the menstrual cycle. They found
that the lowest values of the enzyme are immediately preceding and following
the period of the menses and the highest values occur in the interval between. It
seemed possible that these changes in endometrial activity might be reflected in
the urinary output although Fishman et al. (1951) found no consistent correlationi
between the blood enzyme activity and the phases of the cycle. The function of
,8-glucuronidase is still obscure. Not only is it possible that the enzyme might
be involved in the synthesis of oestrogen and pregnanediol glucuronides, although
this is now considered unlikely, but it might also be involved in structural pro-
liferation of the uterus in the phase before ovulation and in the production of
mucin in the secretory phase. In women, cancer of the bladder usually occurs in
the post-menopausal stage and the enzyme determinations would not be affected
by any cyclical changes. It was thought at the beginning ofthis investigation that
in the control groups, where there was a greater number of younger women, the
menstrual cycle might have affected the enzyme activity. If, however, ,8-glu-
curonidase plays a ro'le in any of the metabolic processes during the menstrual
cycle it was not evident in the urinary activity of the small series investigated.
With regard to the increased urinary enzyme activity found after some opera-
tions and apparently associated with fairly large amounts of tissue proliferation,
Levvy's review (1956) must be borne in mind in which he emphasises that there
are many results obtained by different workers which do not support the general-
isation that ,8-glucuronidase activity is invariably related to tissue growth.
Although this might be the reason for the elevation during the healing of fractures
there may be arelationship between hydrolysis of chondroitin and other mucopoly-
saccharides and the enzyme activity, as suggested by Levvy (1956).
It is possible that the discrepancy between the results of Boyland et al. (1955)
and those reported here is due to a difference in the stage of the disease when the
patient was investigated. The patients investigated at Southmead Hospital
(except for three of the cases in Table IV) were fairly fit and were able to resume
normal activities upon discharge after review cystoscopy. In advanced, inoperable
cases, even where the pH of the urine is normal, it is feasible that contamination
of the urine from the tumour tissue which, Boyland and his colleagues (1955)
118URINARY /-GLUCURONIDASE ACTIVITY
have shown to contain high enzyme activity, would cause an increased urinary
activity. Our results on the enzyme activity of the urinary sediments from
patients with cancer present in the bladder were inconclusive. On the other hand,
Boyland's cases may also have had significant bony metastases, another differential
feature from ours. It was considered possible that as new bone formation was
associated with an increase in the urinary glucuronidase activity, some forms of
metastases in bone might have a similar effect. To date a small series of results
in patients with such metastases (unpublished) has not been helpful, possibly oIn
account of the steroid hormone therapy given.
Since this was written our attention has been drawn to two recent papers
concerned with urinary 83-glucuronidase activity in patients with cancer of the
bladder. Ohkubo, Sonoda and Kusonoki (1958) in an investigation of the enzyme
values of serum, urine and tissue of patients with urological diseases found that
in 6 out of 7 cases of bladder cancer the urinary enzyme values were higher than
in 16 normal subjects. Mattea and Pietra (1959) observed that in 30 subjects witlh
industrial cancer of the bladder 29 had increased enzyme activity in urine diluted
ten times compared with the activity ofsimilarly diluted urine of 4 normal subjects.
The absolute values obtained by the authors of these two papers cannot be
directly compared with each other, with the results of Boyland et (l. (1957) or
with the results in the present paper, since experimental factors such as urine and
substrate concenitration differed.
SUMMARY
1. Urinary f3-glucuronidase activity was estimated in patients with cancer of
the bladder and in a large number ofcontrols, including patients with otherdiseases, in addition to normal subjects.
2. 8-glucuronidase inhibitors were found in 86 per cent of the men and 52 per
cent of the women investigated for this effect.
3. The enzyme activity per ml. urine as well as the daily output were both
significantly higher than normal in some cases after major surgery anld also, for
at least 10 days after fractures.
4. Apart from this the enzyme activity per ml. urine was not significanitly
different in cancer of the bladder from that in normal subjects or in any of the
diseases investigated.
5. The 24-hour output of the enzyme was significantly increased in cancer of
the bladder and in other genito-urinary diseases. Data are presented which
appear to correlate this increase with the increased volume of urine excreted by
such patients.
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